Nuvation Bio Inc.
Clinical trials sponsored by Nuvation Bio Inc., explained in plain language.
-
Targeted cancer drug trial halted early: what happened?
Disease control TerminatedThis study tested a daily pill called AB-106 in people whose advanced solid tumors had a specific genetic change (NTRK fusion). The goal was to see if the drug could shrink tumors. The trial was stopped early after enrolling only 14 participants. It was designed for patients who …
Phase: PHASE2 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New cancer drug trial halted early – what we know
Disease control TerminatedThis early-stage trial tested an experimental drug called NUV-868, alone or with other cancer drugs, in 82 adults with advanced solid tumors (including ovarian, pancreatic, prostate, and breast cancers). The goal was to find safe doses and check for early signs of effectiveness. …
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC